Pages that link to "Q44662364"

The following pages link to Preliminary results on the influence of chemoradiation on apparent diffusion coefficients of primary rectal carcinoma measured by magnetic resonance imaging (Q44662364):

Displaying 41 items.

• Therapy response with diffusion MRI: an update (Q26851700) (← links)
• Diffusion weighted MRI: overview and implications for rectal cancer management. (Q30615815) (← links)
• Diffusion-weighted magnetic resonance imaging in management of bladder cancer, particularly with multimodal bladder-sparing strategy (Q30834007) (← links)
• Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response (Q30986317) (← links)
• Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma (Q31015437) (← links)
• Diffusion MRI in early cancer therapeutic response assessment (Q31037179) (← links)
• The functional diffusion map: an imaging biomarker for the early prediction of cancer treatment outcome (Q31043513) (← links)
• A feasibility study of parametric response map analysis of diffusion-weighted magnetic resonance imaging scans of head and neck cancer patients for providing early detection of therapeutic efficacy (Q33496147) (← links)
• Diffusion-weighted MRI for assessment of early cancer treatment response (Q33588005) (← links)
• Measuring the apparent diffusion coefficient in primary rectal tumors: is there a benefit in performing histogram analyses? (Q33841515) (← links)
• Response Monitoring with [18F]FLT PET and Diffusion-Weighted MRI After Cytotoxic 5-FU Treatment in an Experimental Rat Model for Colorectal Liver Metastases (Q33875886) (← links)
• Predicting and monitoring cancer treatment response with diffusion-weighted MRI. (Q34052992) (← links)
• Use of new imaging techniques to predict tumour response to therapy (Q34096601) (← links)
• Magnetic resonance imaging: A potential tool in assessing the addition of hyperthermia to neoadjuvant therapy in patients with locally advanced breast cancer (Q34390068) (← links)
• Clinical significance of magnetic resonance imaging findings in rectal cancer (Q34885147) (← links)
• Diffusion-weighted magnetic resonance application in response prediction before, during, and after neoadjuvant radiochemotherapy in primary rectal cancer carcinoma (Q34927668) (← links)
• Applications of Molecular Imaging (Q35082412) (← links)
• Diffusion-weighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: a multicenter study. (Q35106508) (← links)
• Quantitative Assessment of Diffusion-Weighted MR Imaging in Patients with Primary Rectal Cancer: Correlation with FDG-PET/CT (Q35230789) (← links)
• Tumour ADC measurements in rectal cancer: effect of ROI methods on ADC values and interobserver variability. (Q35552604) (← links)
• Effectiveness of the apparent diffusion coefficient for predicting the response to chemoradiation therapy in locally advanced rectal cancer: a systematic review and meta-analysis (Q35559783) (← links)
• Functional diffusion map as an early imaging biomarker for high-grade glioma: correlation with conventional radiologic response and overall survival (Q35698555) (← links)
• Diffusion MRI with Semi-Automated Segmentation Can Serve as a Restricted Predictive Biomarker of the Therapeutic Response of Liver Metastasis (Q36315964) (← links)
• Combined value of apparent diffusion coefficient-standardized uptake value max in evaluation of post-treated locally advanced rectal cancer (Q36419166) (← links)
• New developments in MRI for target volume delineation in radiotherapy (Q36596308) (← links)
• Utility of magnetic resonance imaging in anorectal disease (Q36859114) (← links)
• The role of perfusion effects in monitoring of chemoradiotherapy of rectal carcinoma using diffusion-weighted imaging (Q37394881) (← links)
• Role of MRI for staging of rectal cancer (Q37449042) (← links)
• Diffusion-weighted MRI in abdominal oncology: clinical applications. (Q37689666) (← links)
• Statistical power in quantitative diffusion MRI of tumor response: strategies for future studies (Q37969383) (← links)
• Evaluation of treatment-associated inflammatory response on diffusion-weighted magnetic resonance imaging and 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography imaging biomarkers (Q39747261) (← links)
• The use of FDG-PET/CT and diffusion-weighted magnetic resonance imaging for response prediction before, during and after preoperative chemoradiotherapy for rectal cancer. (Q43002292) (← links)
• Diffusion-weighted magnetic resonance imaging in the early detection of response to chemoradiation in cervical cancer. (Q43480237) (← links)
• Performance of diffusion-weighted magnetic resonance imaging at 3.0T for early assessment of tumor response in locally advanced rectal cancer treated with preoperative chemoradiation therapy (Q48248125) (← links)
• Diffusion-weighted MRI in rectal cancer: apparent diffusion coefficient as a potential noninvasive marker of tumor aggressiveness. (Q51439645) (← links)
• Prognostic implications of diffusion-weighted magnetic resonance imaging in patients with superior sulcus tumors receiving induction chemoradiation therapy. (Q52885945) (← links)
• Response evaluation after neoadjuvant treatment for rectal cancer using modern MR imaging: a pictorial review (Q64242805) (← links)
• Apparent diffusion coefficient for evaluating tumour response to neoadjuvant chemoradiation therapy for locally advanced rectal cancer (Q82070892) (← links)
• Initial experience of diffusion-weighted magnetic resonance imaging to assess therapeutic response to induction chemoradiotherapy against muscle-invasive bladder cancer (Q84904285) (← links)
• Colorectal cancer: Parametric evaluation of morphological, functional and molecular tomographic imaging (Q90318346) (← links)
• Diffusion-weighted imaging in rectal cancer: current applications and future perspectives (Q93104772) (← links)